
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Q We live in an age of dichotomies—"extra-value meals" and "supersizing" are as common as diets like the Atkins diet and South Beach diet.






